Research
Research
September 17, 2026 • 6 Min
A New Approach to MEK Inhibition for First-Line Treatment
Dr. Eileen O’Reilly outlines a phase III trial of a targeted therapy for patients with metastatic pancreatic cancer.
An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.
Research
July 22, 2026 • 5 Min
Tackling KRAS G12D
Dr. Leon Pappas explains the workings of the new KRAS G12D inhibitor, now in phase I/II clinical trials around the US and Australia.
Research
June 29, 2026 • 3 Min
ASCO 2026: An Update on Research
Daraxonrasib wasn’t the only research news to come out at ASCO 2026. Learn about other new drugs and tests for pancreatic cancer.
Survivor Stories
Survivor Stories
November 2, 2022 • 3 Min
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Survivor Stories
June 27, 2022 • 4 Min
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
Survivor Stories
June 1, 2022 • 5 Min
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.
